Notley et al. (2008) showed in mouse model of RA that inhibition of TNF with soluble receptor or monoclonal antibodies (mAbs) led to increased production of IL-17 and expansion of IL-17+/CD4+ cells in lymph nodes. Here, CD4 is linked to rheumatoid arthritis.